These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20150613)

  • 1. Evaluation of [99mTc-(CO)3-X-Y-Bombesin(7-14)NH2] conjugates for targeting gastrin-releasing peptide receptors overexpressed on breast carcinoma.
    Retzloff LB; Heinzke L; Figureoa SD; Sublett SV; Ma L; Sieckman GL; Rold TL; Santos I; Hoffman TJ; Smith CJ
    Anticancer Res; 2010 Jan; 30(1):19-30. PubMed ID: 20150613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3.
    Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Kannan R; Volkert WA; Hoffman TJ
    Cancer Res; 2003 Jul; 63(14):4082-8. PubMed ID: 12874010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
    Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ
    Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties.
    Smith CJ; Gali H; Sieckman GL; Higginbotham C; Volkert WA; Hoffman TJ
    Bioconjug Chem; 2003; 14(1):93-102. PubMed ID: 12526698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organometallic 99mTc(III) '4 + 1' bombesin(7-14) conjugates: synthesis, radiolabeling, and in vitro/in vivo studies.
    Kunstler JU; Veerendra B; Figueroa SD; Sieckman GL; Rold TL; Hoffman TJ; Smith CJ; Pietzsch HJ
    Bioconjug Chem; 2007; 18(5):1651-61. PubMed ID: 17663527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor.
    Lane SR; Veerendra B; Rold TL; Sieckman GL; Hoffman TJ; Jurisson SS; Smith CJ
    Nucl Med Biol; 2008 Apr; 35(3):263-72. PubMed ID: 18355681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
    Faintuch BL; Teodoro R; Duatti A; Muramoto E; Faintuch S; Smith CJ
    Nucl Med Biol; 2008 May; 35(4):401-11. PubMed ID: 18482677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
    Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.
    Nock B; Nikolopoulou A; Chiotellis E; Loudos G; Maintas D; Reubi JC; Maina T
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):247-58. PubMed ID: 12552343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells.
    Smith CJ; Gali H; Sieckman GL; Hayes DL; Owen NK; Mazuru DG; Volkert WA; Hoffman TJ
    Nucl Med Biol; 2003 Feb; 30(2):101-9. PubMed ID: 12623108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells.
    Hoffman TJ; Gali H; Smith CJ; Sieckman GL; Hayes DL; Owen NK; Volkert WA
    J Nucl Med; 2003 May; 44(5):823-31. PubMed ID: 12732685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo evaluation of Alexa Fluor 680-bombesin[7-14]NH2 peptide conjugate, a high-affinity fluorescent probe with high selectivity for the gastrin-releasing peptide receptor.
    Ma L; Yu P; Veerendra B; Rold TL; Retzloff L; Prasanphanich A; Sieckman G; Hoffman TJ; Volkert WA; Smith CJ
    Mol Imaging; 2007; 6(3):171-80. PubMed ID: 17532883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [(99m)Tc]Demomedin C, a radioligand based on human gastrin releasing peptide(18-27): synthesis and preclinical evaluation in gastrin releasing peptide receptor-expressing models.
    Nock BA; Cescato R; Ketani E; Waser B; Reubi JC; Maina T
    J Med Chem; 2012 Oct; 55(19):8364-74. PubMed ID: 22966957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
    Okarvi SM; Al Jammaz I
    Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Gastrin Releasing Peptide Receptor-Directed [
    Nock BA; Charalambidis D; Sallegger W; Waser B; Mansi R; Nicolas GP; Ketani E; Nikolopoulou A; Fani M; Reubi JC; Maina T
    J Med Chem; 2018 Apr; 61(7):3138-3150. PubMed ID: 29517903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, radiolabelling and biological characteristics of a bombesin peptide analog as a tumor imaging agent.
    Okarvi SM; al-Jammaz I
    Anticancer Res; 2003; 23(3B):2745-50. PubMed ID: 12894569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women.
    Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Pichardo-Romero PA
    Nucl Med Commun; 2008 Aug; 29(8):741-7. PubMed ID: 18753829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and exploration of novel radiolabeled bombesin peptides for targeting receptor positive tumor.
    De K; Banerjee I; Sinha S; Ganguly S
    Peptides; 2017 Mar; 89():17-34. PubMed ID: 28088445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New [99mTc]bombesin analogues with improved biodistribution for targeting gastrin releasing-peptide receptor-positive tumors.
    García Garayoa E; Schweinsberg C; Maes V; Rüegg D; Blanc A; Bläuenstein P; Tourwé DA; Beck-Sickinger AG; Schubiger PA
    Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):42-50. PubMed ID: 17372572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
    Garrison JC; Rold TL; Sieckman GL; Figueroa SD; Volkert WA; Jurisson SS; Hoffman TJ
    J Nucl Med; 2007 Aug; 48(8):1327-37. PubMed ID: 17631556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.